BHMTCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。BHMT遺伝子サイレンサーは、BHMT CRISPR/Cas9ノックアウトプラスミドとBHMTDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のBHMTCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
BHMT CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
BHMT CRISPR/Cas9 KOプラスミド (h) | sc-405772 | h | Gene Knockout | GFP | 0 | ||
BHMT HDRプラスミド (h) | sc-405772-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
BHMT Double Nickaseプラスミド (h) | sc-405772-NIC | h | Gene Knockout | Puromycin | 0 | ||
BHMT Double Nickaseプラスミド (h2) | sc-405772-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
BHMT CRISPR/Cas9 KOプラスミド (m) | sc-419327 | m | Gene Knockout | GFP | 0 | ||
BHMT HDRプラスミド (m) | sc-419327-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
BHMT Double Nickaseプラスミド (m) | sc-419327-NIC | m | Gene Knockout | Puromycin | 0 | ||
BHMT Double Nickaseプラスミド (m2) | sc-419327-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
BHMT2 CRISPR/Cas9 KOプラスミド (h) | sc-411782 | h | Gene Knockout | GFP | 0 | ||
BHMT2 HDRプラスミド (h) | sc-411782-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
BHMT2 Double Nickaseプラスミド (h) | sc-411782-NIC | h | Gene Knockout | Puromycin | 0 | ||
BHMT2 Double Nickaseプラスミド (h2) | sc-411782-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
BHMT2 CRISPR/Cas9 KOプラスミド (m) | sc-425737 | m | Gene Knockout | GFP | 0 | ||
BHMT2 HDRプラスミド (m) | sc-425737-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
BHMT2 Double Nickaseプラスミド (m) | sc-425737-NIC | m | Gene Knockout | Puromycin | 0 | ||
BHMT2 Double Nickaseプラスミド (m2) | sc-425737-NIC-2 | m | Gene Knockout | Puromycin | 0 |
BHMT CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
BHMT CRISPR Activationプラスミド (h) | sc-405772-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT CRISPR Activationプラスミド (h2) | sc-405772-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT Lentiviral Activation Particles (h) | sc-405772-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT Lentiviral Activation Particles (h2) | sc-405772-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT CRISPR Activationプラスミド (m) | sc-419327-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT CRISPR Activationプラスミド (m2) | sc-419327-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT Lentiviral Activation Particles (m) | sc-419327-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT Lentiviral Activation Particles (m2) | sc-419327-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT2 CRISPR Activationプラスミド (h) | sc-411782-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT2 CRISPR Activationプラスミド (h2) | sc-411782-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT2 Lentiviral Activation Particles (h) | sc-411782-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT2 Lentiviral Activation Particles (h2) | sc-411782-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT2 CRISPR Activationプラスミド (m) | sc-425737-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT2 CRISPR Activationプラスミド (m2) | sc-425737-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT2 Lentiviral Activation Particles (m) | sc-425737-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BHMT2 Lentiviral Activation Particles (m2) | sc-425737-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |